Still always seems so negative due to the baseline or placebo being no different . No mention of relativity versus the normal rate of deterioration or progression of the disease . Still surprises me with the various recognised as 'best available' indicators which LCT has used during the trial that the normal degradation of these measures is never referenced, rather just the relativity versus the very small sham group. At what point should the sham group be deemed irrelevant or a ridiculous conclusion that just having a procedure is indeed all that is required to stop the profession of Parkinson's.
Recent events, page-74
-
- There are more pages in this discussion • 108 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add 1AI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.49M | |||
| Open | High | Low | Value | Volume |
| 0.9¢ | 0.9¢ | 0.8¢ | $17.46K | 2.182M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 4501358 | 0.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.9¢ | 2830688 | 15 |
View Market Depth
| Last trade - 16.10pm 05/08/2024 (20 minute delay) ? |
| 1AI (ASX) Chart |